BABA vs BZH

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

BZH presents a contradictory profile: it is fundamentally cheap on an asset basis (P/B 0.53) but experiencing a severe operational collapse. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while the current price of $22.45 sits significantly above the Graham Number ($16.55) and the growth-based intrinsic value ($2.03). With revenue declining by 22.5% YoY and a massive YoY EPS drop of 1150%, the company is currently in a sharp downward trajectory despite high liquidity.